[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-001", "question": "A 65-year-old male with ARDS is deeply sedated and paralyzed on volume-control ventilation. Paralysis is paused for a 'sedation holiday.' The ventilator waveform display subsequently shows a controlled breath delivered by the machine, followed immediately by a deflection in the flow waveform suggesting patient effort, which then triggers a second, stacked breath. Esophageal manometry reveals that the diaphragm electrical activity (EAdi) and negative esophageal pressure swing onset occur *after* the initiation of the first machine-delivered breath. What is the specific dyssynchrony described?", "options": ["Double triggering", "Reverse triggering", "Ineffective triggering", "Autocycling", "Flow starvation"], "answer": "B", "answer_index": 1, "explanation": "This is reverse triggering (entrainment). Unlike double triggering (where a sustained patient effort triggers two breaths), reverse triggering is a reflex where the mechanical inflation of the lung stretches the diaphragm, inducing a muscle contraction *after* the breath has started. This contraction can then trigger a second breath (breath stacking). The key distinction is the timing of the patient's effort relative to the machine cycle.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To identify the specific dyssynchrony described in this scenario, I need to analyze the key elements:\n\n1) The patient is receiving volume-control ventilation\n2) A controlled breath is delivered by the machine\n3) Patient effort (diaphragm activity) occurs AFTER the initiation of the first machine breath\n4) This patient effort then triggers a second, stacked breath\n\nThis describes \"reverse triggering,\" which is a phenomenon where the ventilator-delivered breath actually stimulates a reflexive patient effort. The key diagnostic feature is that the patient's respiratory effort (shown by EAdi and negative esophageal pressure) begins after the ventilator has already initiated a breath. This reflexive diaphragmatic contraction then triggers a second breath, creating the \"stacked\" pattern.\n\nThis differs from:\n- Double triggering (where the patient initiates both breaths)\n- Ineffective triggering (where patient effort fails to trigger a breath)\n- Autocycling (where breaths are triggered without patient effort)\n- Flow starvation (where flow delivery is inadequate for patient demand)\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-002", "question": "A 72-year-old male presents with macrocytic anemia, intermittent fevers, and relapsing polychondritis resistant to standard immunosuppression. Bone marrow biopsy reveals vacuoles in myeloid and erythroid precursor cells. Cytogenetics are normal. Which of the following genetic mutations is most likely responsible for this clinical syndrome?", "options": ["JAK2 V617F", "UBA1", "SF3B1", "TET2", "MYD88"], "answer": "B", "answer_index": 1, "explanation": "The patient has VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic), a recently described disorder caused by somatic mutations in the UBA1 gene. It typically affects older men and presents with treatment-refractory inflammatory symptoms (chondritis, vasculitis) and hematologic abnormalities (macrocytic anemia, vacuoles in marrow precursors).", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To answer this question, I need to analyze the clinical presentation and laboratory findings.\n\nThe patient presents with:\n- Macrocytic anemia\n- Intermittent fevers\n- Relapsing polychondritis resistant to standard immunosuppression\n- Vacuoles in myeloid and erythroid precursor cells on bone marrow biopsy\n- Normal cytogenetics\n\nLet me evaluate each option:\n\nA. JAK2 V617F: This mutation is associated with myeloproliferative neoplasms (MPNs) like polycythemia vera, essential thrombocythemia, and primary myelofibrosis. It doesn't typically cause vacuolization or relapsing polychondritis.\n\nB. UBA1: Mutations in UBA1 (Ubiquitin-Like Modifier Activating Enzyme 1) are associated with VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic). This syndrome presents with vacuoles in myeloid and erythroid precursors, macrocytic anemia, fevers, and inflammatory manifestations including relapsing polychondritis. It typically affects older males and is often resistant to standard immunosuppression.\n\nC. SF3B1: This mutation is associated with myelodysplastic syndromes with ring sideroblasts and doesn't typically cause the inflammatory manifestations described.\n\nD. TET2: While TET2 mutations can be seen in myeloid neoplasms, they don't specifically cause vacuolization or the autoinflammatory features described.\n\nE. MYD88: This mutation is associated with Waldenstr√∂m macroglobulinemia and doesn't typically cause the described presentation.\n\nThe clinical picture of an elderly male with macrocytic anemia, fevers, treatment-resistant relapsing polychondritis, and vacuoles in myeloid and erythroid precursors is highly characteristic of VEXAS syndrome, which is caused by somatic mutations in UBA1.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-003", "question": "A 45-year-old victim of a residential fire is intubated for airway protection. Due to suspected cyanide toxicity, a specific antidote is administered. Two hours later, the patient requires continuous renal replacement therapy (CRRT) for severe acidosis and acute kidney injury. Shortly after initiation, the CRRT machine repeatedly alarms and stops due to a 'Blood Leak' error, despite visual inspection of the effluent showing no frank blood. What is the mechanism of this technical complication?", "options": ["Hemolysis induced by the antidote", "Rhabdomyolysis myoglobin filtering", "Optical interference by the antidote", "Precipitation of antidote in the filter", "Coagulation of the filter membrane"], "answer": "C", "answer_index": 2, "explanation": "The patient received hydroxocobalamin (cyanokit), which has an intense red color. This chromophore passes into the ultrafiltrate/dialysate and is detected by the optical blood leak detector of the dialysis machine, causing a false-positive alarm that halts therapy. It also interferes with co-oximetry (falsely elevating HbCO) and colorimetric chemistry labs (creatinine, lactate) for days.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To answer this question, I need to analyze the scenario and identify the likely mechanism causing the CRRT machine's \"Blood Leak\" error.\n\nThe key elements in this case:\n- Fire victim with suspected cyanide toxicity who received an antidote\n- CRRT machine alarming with \"Blood Leak\" errors\n- No visible blood in the effluent\n\nThe common antidotes for cyanide toxicity include:\n1. Hydroxocobalamin (Cyanokit)\n2. Sodium thiosulfate\n3. Amyl nitrite/sodium nitrite\n\nHydroxocobalamin is bright red in color and is known to cause discoloration of bodily fluids. This red coloration can trigger optical sensors in CRRT machines that detect \"blood leaks\" by measuring light absorption or transmission through the effluent. The machine interprets this red coloration as blood, even though no actual blood is present in the effluent.\n\nThe other options are less likely:\n- Hemolysis would cause actual blood components in the effluent\n- Myoglobin would appear as tea-colored, not bright red\n- Precipitation would cause filter clogging, not blood leak alarms\n- Coagulation would cause pressure alarms, not blood leak alarms\n\nThe optical interference from hydroxocobalamin is a well-documented issue with CRRT machines following cyanide poisoning treatment.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-004", "question": "A 3-week-old infant presents with a large, firm, violaceous, indurated plaque on the thigh that has rapidly expanded. Labs reveal profound thrombocytopenia (12,000/microL), hypofibrinogenemia, and elevated D-dimer. The attending physician diagnoses Kasabach-Merritt Phenomenon. Which of the following underlying vascular anomalies is most strongly associated with this complication?", "options": ["Infantile Hemangioma", "Kaposiform Hemangioendothelioma", "Venous Malformation", "Pyogenic Granuloma", "Port-wine Stain"], "answer": "B", "answer_index": 1, "explanation": "Kasabach-Merritt Phenomenon (KMP) is a life-threatening consumptive coagulopathy. Historically, it was incorrectly associated with common Infantile Hemangiomas. It is now known to be exclusively associated with rare, aggressive vascular tumors, specifically Kaposiform Hemangioendothelioma (KHE) and Tufted Angioma. Common infantile hemangiomas do *not* cause KMP.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To answer this question, I need to identify which vascular anomaly is most strongly associated with Kasabach-Merritt Phenomenon (KMP).\n\nKasabach-Merritt Phenomenon is characterized by:\n- A rapidly enlarging vascular lesion\n- Severe thrombocytopenia\n- Coagulopathy with hypofibrinogenemia and elevated D-dimer\n\nLooking at the options:\n\nA. Infantile Hemangioma - While these are common vascular tumors in infants, they are not typically associated with KMP. They usually have a benign course.\n\nB. Kaposiform Hemangioendothelioma (KHE) - This is a rare, aggressive vascular tumor that is strongly associated with KMP. The clinical presentation described (rapidly expanding violaceous plaque with severe thrombocytopenia and coagulopathy) is classic for KHE with KMP.\n\nC. Venous Malformation - These can cause localized intravascular coagulopathy but rarely cause the severe systemic coagulopathy seen in KMP.\n\nD. Pyogenic Granuloma - These are benign vascular lesions that may bleed but do not cause thrombocytopenia or coagulopathy.\n\nE. Port-wine Stain - These are capillary malformations that do not cause hematologic abnormalities.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-005", "question": "A 58-year-old female presents with a 6-month history of progressive gait instability, dysarthria, and severe sleep dysfunction characterized by undifferentiated NREM/REM sleep and stridor. MRI brain is unremarkable. CSF analysis shows normal cell count and protein. Testing for which of the following antibodies is most likely to yield the diagnosis?", "options": ["Anti-Hu", "Anti-Yo", "Anti-IgLON5", "Anti-LGI1", "Anti-GABA-B"], "answer": "C", "answer_index": 2, "explanation": "Anti-IgLON5 disease is a distinct neurological syndrome characterized by a unique sleep disorder (parasomnias, sleep apnea, stridor) and bulbar dysfunction/gait instability. It is a tauopathy that bridges the gap between autoimmunity and neurodegeneration. The sleep architecture is often severely disorganized.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most likely antibody associated with this clinical presentation, I'll analyze the key symptoms and findings:\n\nThe patient presents with:\n- Progressive gait instability\n- Dysarthria\n- Severe sleep dysfunction with undifferentiated NREM/REM sleep and stridor\n- Normal MRI brain\n- Normal CSF analysis\n\nThis clinical picture is highly characteristic of anti-IgLON5 disease, which is a relatively recently described autoimmune disorder. The hallmark features include:\n\n1. Sleep disorders (particularly undifferentiated NREM/REM sleep and stridor during sleep)\n2. Bulbar symptoms (dysarthria)\n3. Gait instability/ataxia\n4. Normal or near-normal MRI findings\n5. Often normal CSF findings\n\nAnti-Hu is typically associated with paraneoplastic encephalomyelitis and sensory neuropathy.\nAnti-Yo is associated with paraneoplastic cerebellar degeneration.\nAnti-LGI1 typically causes limbic encephalitis with seizures and memory impairment.\nAnti-GABA-B is associated with limbic encephalitis and seizures.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-006", "question": "A patient with severe chronic hyponatremia (Na 105 mEq/L) and concomitant hypokalemia (K 2.5 mEq/L) is admitted. The resident orders 40 mEq of IV KCl to correct the potassium. Two hours later, the serum sodium has risen to 112 mEq/L, exceeding the safe correction limit. What is the primary physiological mechanism for this rapid rise in serum sodium?", "options": ["Osmotic demyelination releasing sodium", "Intracellular sodium shift in exchange for potassium", "Aldosterone suppression", "Volume expansion suppression of ADH", "Renal sodium retention"], "answer": "B", "answer_index": 1, "explanation": "Administered potassium enters cells to replenish intracellular stores; to maintain electroneutrality, sodium exits the cells into the extracellular space. Therefore, potassium administration acts osmotically equivalent to sodium administration in raising serum tonicity. Additionally, correcting hypokalemia may improve renal concentrating ability, but the cation exchange is the immediate cause of the rapid sodium rise.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To answer this question, I need to consider the relationship between potassium and sodium correction in a hyponatremic patient.\n\nWhen potassium is severely depleted, as in this case (K 2.5 mEq/L), the body attempts to maintain intracellular tonicity and electrical neutrality. Since potassium is the primary intracellular cation, when it's depleted, hydrogen ions and sodium ions may enter cells to partially replace the missing potassium.\n\nWhen IV potassium is administered to a potassium-depleted patient, the potassium enters the cells. To maintain electrical neutrality, this causes sodium to shift out of cells into the extracellular fluid. This exchange mechanism explains why correcting hypokalemia can lead to a rise in serum sodium concentration.\n\nOption A (osmotic demyelination) is a consequence of too-rapid sodium correction, not its cause.\nOption C (aldosterone suppression) would typically decrease potassium excretion and sodium reabsorption, not rapidly increase serum sodium.\nOption D (volume expansion suppressing ADH) would take longer to manifest and requires significant volume changes.\nOption E (renal sodium retention) would not occur this rapidly.\n\nThe answer is (B)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-007", "question": "A 14-year-old male presents with delayed umbilical stump bleeding as a neonate and now has a history of poor wound healing and recurrent soft tissue hematomas. Standard coagulation screening tests (PT, aPTT, fibrinogen, platelet count) are all consistently normal. A urea solubility test is performed and shows clot dissolution. Which factor deficiency is the diagnosis?", "options": ["Factor VIII", "Factor IX", "Factor XI", "Factor XIII", "Alpha-2-antiplasmin"], "answer": "D", "answer_index": 3, "explanation": "Factor XIII (Fibrin Stabilizing Factor) is responsible for cross-linking fibrin monomers. Deficiency leads to unstable clots that dissolve in 5M urea (or monochloroacetic acid). Because the coagulation cascade up to the formation of the fibrin polymer is intact, the standard PT and aPTT are normal. The clinical hallmark is delayed bleeding (e.g., umbilical stump) and poor wound healing.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "To solve this question, I need to analyze the clinical presentation and laboratory findings.\n\nKey clinical features:\n- Delayed umbilical stump bleeding (not immediate)\n- Poor wound healing\n- Recurrent soft tissue hematomas\n- Normal PT, aPTT, fibrinogen, and platelet count\n- Positive urea solubility test (clot dissolution)\n\nThe normal PT and aPTT rule out deficiencies in the extrinsic, intrinsic, and common pathways (including factors VIII, IX, and XI). This immediately eliminates options A, B, and C.\n\nFactor XIII (fibrin stabilizing factor) is responsible for cross-linking fibrin polymers to form a stable clot. A deficiency in Factor XIII leads to:\n- Normal initial clot formation (explaining normal screening tests)\n- Poor clot stability (explaining delayed bleeding)\n- Impaired wound healing\n- Soft tissue bleeding\n\nThe urea solubility test specifically tests for Factor XIII deficiency. In this test, a normal clot remains intact in urea solution due to cross-linked fibrin, while a Factor XIII-deficient clot dissolves.\n\nAlpha-2-antiplasmin deficiency would cause a fibrinolytic disorder but would not typically present with the specific pattern described, particularly the delayed umbilical stump bleeding.\n\nThe answer is (D)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-008", "question": "A 22-year-old male is brought to the ED after ingesting a rodenticide. He is alert but complains of extreme weakness. Examination reveals generalized flaccid paralysis. ECG shows premature ventricular complexes. Labs show a serum potassium of 1.8 mEq/L. Which toxin is most likely responsible, and what is the mechanism?", "options": ["Arsenic; uncoupling of oxidative phosphorylation", "Thallium; substitution for potassium in ATPase", "Barium; blockade of potassium efflux channels", "Strychnine; glycine receptor antagonism", "Sodium monofluoroacetate; aconitase inhibition"], "answer": "C", "answer_index": 2, "explanation": "Barium carbonate (found in certain rodenticides and ceramics) causes profound hypokalemia by blocking the inward rectifier potassium channels (Kir), preventing potassium efflux from cells, while the Na-K-ATPase continues to pump potassium in. This results in severe intracellular shift of potassium, leading to paralysis and arrhythmias. Treatment requires aggressive potassium replacement.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most likely toxin responsible for this patient's symptoms, I'll analyze the clinical presentation and match it with the known mechanisms of the listed rodenticides.\n\nThe key findings in this case are:\n- Generalized flaccid paralysis\n- Severe hypokalemia (K+ 1.8 mEq/L)\n- Premature ventricular complexes\n- Extreme weakness\n\nLooking at the options:\n\nA. Arsenic typically causes GI symptoms, garlic odor, and peripheral neuropathy. While it does uncouple oxidative phosphorylation, severe hypokalemia is not a hallmark feature.\n\nB. Thallium can cause weakness and neuropathy, but its primary mechanism involves substituting for potassium in Na+/K+ ATPase. While this can affect potassium levels, the profound hypokalemia seen here is not characteristic.\n\nC. Barium is a rodenticide that blocks potassium efflux channels, preventing potassium from exiting cells. This leads to profound hypokalemia, muscle weakness progressing to flaccid paralysis, and cardiac arrhythmias - exactly matching this patient's presentation.\n\nD. Strychnine causes increased muscle tone and convulsions (not flaccid paralysis) by antagonizing glycine receptors.\n\nE. Sodium monofluoroacetate causes metabolic acidosis and seizures through aconitase inhibition, not the hypokalemia and flaccid paralysis seen here.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-009", "question": "A 2-year-old boy presents with failure to thrive and chronic steatorrhea. Examination reveals absent deep tendon reflexes and ataxia. A peripheral blood smear demonstrates numerous acanthocytes. A lipid panel shows extremely low levels of cholesterol and triglycerides, and absent LDL. Which of the following is the primary pathophysiology?", "options": ["Defect in the LDL receptor", "Mutation in the ABCA1 gene", "Microsomal triglyceride transfer protein (MTP) deficiency", "Lipoprotein lipase deficiency", "Apolipoprotein C-II deficiency"], "answer": "C", "answer_index": 2, "explanation": "This is Abetalipoproteinemia (Bassen-Kornzweig syndrome). It is caused by a mutation in the MTP gene, which is required for the assembly and secretion of apoB-containing lipoproteins (Chylomicrons, VLDL, LDL). The absence of these lipoproteins leads to fat malabsorption (steatorrhea), vitamin E deficiency (spinocerebellar degeneration, absent DTRs), and lipid membrane defects (acanthocytosis).", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To solve this question, I need to analyze the clinical presentation and laboratory findings.\n\nKey findings:\n- 2-year-old with failure to thrive and chronic steatorrhea\n- Neurological symptoms: absent deep tendon reflexes and ataxia\n- Acanthocytes on blood smear\n- Extremely low cholesterol and triglycerides\n- Absent LDL\n\nThis presentation is consistent with abetalipoproteinemia, a rare autosomal recessive disorder characterized by:\n- Fat malabsorption (causing steatorrhea and failure to thrive)\n- Neurological manifestations due to vitamin E deficiency\n- Acanthocytosis (spiky red blood cells)\n- Very low levels of plasma lipids, especially LDL\n\nThe underlying defect in abetalipoproteinemia is a mutation in the microsomal triglyceride transfer protein (MTP) gene. MTP is essential for the assembly and secretion of apolipoprotein B-containing lipoproteins (VLDL and chylomicrons). Without functional MTP, these lipoproteins cannot be formed, leading to the absence of LDL (which is derived from VLDL) and the clinical manifestations described.\n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-010", "question": "A 40-year-old male with a history of migraine with aura presents with cognitive decline and a recent lacunar stroke. He has no hypertension or vascular risk factors. MRI of the brain reveals extensive white matter hyperintensities, specifically involving the anterior temporal poles and external capsules. Genetic testing would likely reveal a mutation in which gene?", "options": ["NOTCH3", "GLA", "HTRA1", "APP", "COL4A1"], "answer": "A", "answer_index": 0, "explanation": "This is the classic presentation of CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy). The mutation is in the *NOTCH3* gene. The MRI finding of hyperintensities in the anterior temporal poles is highly sensitive and specific for CADASIL, distinguishing it from chronic hypertensive microangiopathy.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To answer this question, I need to consider the clinical presentation and MRI findings to identify the most likely genetic disorder.\n\nThe key features in this case are:\n- 40-year-old male\n- Migraine with aura\n- Cognitive decline\n- Lacunar stroke without typical vascular risk factors\n- MRI showing white matter hyperintensities, specifically in anterior temporal poles and external capsules\n\nThese findings are highly characteristic of CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), which is caused by mutations in the NOTCH3 gene. CADASIL typically presents with:\n- Migraine with aura (often the earliest symptom)\n- Recurrent strokes at a young age without typical vascular risk factors\n- Progressive cognitive decline\n- Characteristic MRI findings with white matter hyperintensities, with involvement of anterior temporal poles and external capsules being highly specific for this condition\n\nThe other genes listed are associated with different conditions:\n- GLA: Fabry disease\n- HTRA1: CARASIL (recessive form with different presentation)\n- APP: Alzheimer's disease and cerebral amyloid angiopathy\n- COL4A1: Small vessel disease with different MRI pattern\n\nThe answer is (A)"}]